1-2 of 2
Investigator-Initiated Trials
Close
Sort by
Journal Articles

Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial

Clinical Trials & Observations
Ulrich Dührsen, Andreas Bockisch, Bernd Hertenstein, Imke E. Karsten, Frank Kroschinsky, Michael Heuser, Andreas Hochhaus, Heinz-Gert Höffkes, Dirk Behringer, Gabriele Prange-Krex, Mareike Tometten, Martin Grieshammer, Götz U. Grigoleit, Oliver Schmalz, Karin Jordan, Helga Bernhard, Tobias Gaska, Aristoteles Giagounidis, Roland Schroers, Uwe M. Martens, Gerhard Held, Wolfram Klapper, Karl-Heinz Jöckel, Michael Nonnemacher, Andreas Hüttmann
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100018.
https://doi.org/10.1016/j.bneo.2024.100018
Published: 2024
Includes: Supplemental data
Journal Articles

KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study

Clinical Trials & Observations
Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Takero Shindo, Satoshi Iyama, Junki Inamura, Takafumi Nakao, Tsutomu Kobayashi, Eri Kawata, Hiroshi Ohkawara, Takayuki Ikezoe, Atsushi Kawaguchi, Shinya Kimura
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (1): 100001.
https://doi.org/10.1016/j.bneo.2024.100001
Published: 2024
Includes: Supplemental data